Updates in the diagnosis and management of small-bowel Crohn's disease

Cristina Carretero; Alejandro Bojorquez; Rami Eliakim; Nikolaos Lazaridis

doi:10.1016/j.bpg.2023.101855

Updates in the diagnosis and management of small-bowel Crohn's disease

Cristina Carretero^*
, Alejandro Bojorquez
, Rami Eliakim
, Nikolaos Lazaridis

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Original language	English
Article number	101855
Journal	Best Practice and Research: Clinical Gastroenterology
Volume	64-65
DOIs	https://doi.org/10.1016/j.bpg.2023.101855
State	Published - 1 Jun 2023

Funding

Funders
International Organization for Inflammatory Bowel Disease

Access to Document

10.1016/j.bpg.2023.101855

Cite this

@article{ba28d7c88a6a4d939beb615af68165d2,

title = "Updates in the diagnosis and management of small-bowel Crohn's disease",

author = "Cristina Carretero and Alejandro Bojorquez and Rami Eliakim and Nikolaos Lazaridis",

note = "Funding Information: According to ECCO-ESGAR guidelines, the diagnosis of CD can be supported when three or more SB ulcers are identified at CE in the absence of non-steroidal anti-inflammatory drug use (>30 days) [10]. The combination of the “red-flag” questionnaire from The International Organization for Inflammatory Bowel Disease (IO-IBD) with elevated levels of FCP can identify patients with a high probability of CD [25]. FCP levels below 50 μg/g have been suggested as a negative predictive factor for CE findings [33] while a cut-off level of 95–100 μg/g seems a more accurate screening tool to select patients that should undergo CE [34,35]. Nevertheless, the correlation between diagnostic tools and CE findings remains inconclusive [36].",

year = "2023",

month = jun,

day = "1",

doi = "10.1016/j.bpg.2023.101855",

language = "אנגלית",

volume = "64-65",

journal = "Best Practice and Research: Clinical Gastroenterology",

issn = "1521-6918",

publisher = "Bailliere Tindall Ltd",

}

TY - JOUR

T1 - Updates in the diagnosis and management of small-bowel Crohn's disease

AU - Carretero, Cristina

AU - Bojorquez, Alejandro

AU - Eliakim, Rami

AU - Lazaridis, Nikolaos

N1 - Funding Information: According to ECCO-ESGAR guidelines, the diagnosis of CD can be supported when three or more SB ulcers are identified at CE in the absence of non-steroidal anti-inflammatory drug use (>30 days) [10]. The combination of the “red-flag” questionnaire from The International Organization for Inflammatory Bowel Disease (IO-IBD) with elevated levels of FCP can identify patients with a high probability of CD [25]. FCP levels below 50 μg/g have been suggested as a negative predictive factor for CE findings [33] while a cut-off level of 95–100 μg/g seems a more accurate screening tool to select patients that should undergo CE [34,35]. Nevertheless, the correlation between diagnostic tools and CE findings remains inconclusive [36].

PY - 2023/6/1

Y1 - 2023/6/1

UR - https://www.scopus.com/pages/publications/85169357676

U2 - 10.1016/j.bpg.2023.101855

DO - 10.1016/j.bpg.2023.101855

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 37652654

AN - SCOPUS:85169357676

SN - 1521-6918

VL - 64-65

JO - Best Practice and Research: Clinical Gastroenterology

JF - Best Practice and Research: Clinical Gastroenterology

M1 - 101855

ER -

Updates in the diagnosis and management of small-bowel Crohn's disease

Funding

Access to Document

Other files and links

Cite this